NJSの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/10/11 | 1,420 | 1,420 | 1,408 | 1,408 | -11 | -0.8% | 5,200 |
2017/10/10 | 1,414 | 1,419 | 1,399 | 1,419 | +15 | +1.1% | 12,900 |
2017/10/06 | 1,407 | 1,409 | 1,397 | 1,404 | -5 | -0.4% | 3,500 |
2017/10/05 | 1,411 | 1,414 | 1,401 | 1,409 | -2 | -0.1% | 4,000 |
2017/10/04 | 1,400 | 1,413 | 1,398 | 1,411 | +8 | +0.6% | 5,700 |
2017/10/03 | 1,410 | 1,410 | 1,400 | 1,403 | -7 | -0.5% | 5,100 |
2017/10/02 | 1,400 | 1,413 | 1,392 | 1,410 | +13 | +0.9% | 10,800 |
2017/09/29 | 1,384 | 1,400 | 1,384 | 1,397 | ±0 | ±0% | 6,600 |
2017/09/28 | 1,399 | 1,399 | 1,391 | 1,397 | -1 | -0.1% | 4,700 |
2017/09/27 | 1,399 | 1,399 | 1,393 | 1,398 | -1 | -0.1% | 4,400 |
2017/09/26 | 1,382 | 1,399 | 1,382 | 1,399 | +17 | +1.2% | 8,600 |
2017/09/25 | 1,384 | 1,386 | 1,376 | 1,382 | +7 | +0.5% | 6,500 |
2017/09/22 | 1,375 | 1,378 | 1,372 | 1,375 | +8 | +0.6% | 2,000 |
2017/09/21 | 1,364 | 1,369 | 1,363 | 1,367 | +3 | +0.2% | 2,800 |
2017/09/20 | 1,369 | 1,374 | 1,362 | 1,364 | -6 | -0.4% | 9,000 |
2017/09/19 | 1,370 | 1,378 | 1,367 | 1,370 | ±0 | ±0% | 5,700 |
2017/09/15 | 1,373 | 1,383 | 1,364 | 1,370 | -8 | -0.6% | 6,100 |
2017/09/14 | 1,375 | 1,398 | 1,360 | 1,378 | +6 | +0.4% | 23,500 |
2017/09/13 | 1,375 | 1,382 | 1,370 | 1,372 | -1 | -0.1% | 4,800 |
2017/09/12 | 1,375 | 1,377 | 1,364 | 1,373 | +1 | +0.1% | 6,000 |
2017/09/11 | 1,378 | 1,378 | 1,366 | 1,372 | -6 | -0.4% | 2,100 |
2017/09/08 | 1,364 | 1,380 | 1,364 | 1,378 | -4 | -0.3% | 4,600 |
2017/09/07 | 1,376 | 1,384 | 1,376 | 1,382 | +6 | +0.4% | 1,700 |
2017/09/06 | 1,365 | 1,380 | 1,365 | 1,376 | -3 | -0.2% | 3,600 |
2017/09/05 | 1,400 | 1,400 | 1,361 | 1,379 | -6 | -0.4% | 8,400 |
2017/09/04 | 1,364 | 1,385 | 1,364 | 1,385 | +1 | +0.1% | 5,700 |
2017/09/01 | 1,379 | 1,388 | 1,379 | 1,384 | +1 | +0.1% | 1,700 |
2017/08/31 | 1,391 | 1,391 | 1,376 | 1,383 | +4 | +0.3% | 1,900 |
2017/08/30 | 1,389 | 1,389 | 1,369 | 1,379 | +10 | +0.7% | 2,100 |
2017/08/29 | 1,373 | 1,376 | 1,366 | 1,369 | -4 | -0.3% | 1,800 |
2017/08/28 | 1,381 | 1,382 | 1,361 | 1,373 | +6 | +0.4% | 3,900 |
2017/08/25 | 1,370 | 1,373 | 1,364 | 1,367 | -1 | -0.1% | 4,500 |
2017/08/24 | 1,368 | 1,372 | 1,366 | 1,368 | +3 | +0.2% | 4,500 |
2017/08/23 | 1,374 | 1,374 | 1,357 | 1,365 | -3 | -0.2% | 5,400 |
2017/08/22 | 1,363 | 1,370 | 1,363 | 1,368 | +5 | +0.4% | 2,000 |
2017/08/21 | 1,361 | 1,367 | 1,351 | 1,363 | +2 | +0.1% | 3,700 |
2017/08/18 | 1,376 | 1,376 | 1,361 | 1,361 | -8 | -0.6% | 4,900 |
2017/08/17 | 1,380 | 1,380 | 1,361 | 1,369 | -3 | -0.2% | 2,900 |
2017/08/16 | 1,367 | 1,376 | 1,365 | 1,372 | +5 | +0.4% | 3,700 |
2017/08/15 | 1,382 | 1,382 | 1,364 | 1,367 | +15 | +1.1% | 4,700 |
2017/08/14 | 1,385 | 1,385 | 1,352 | 1,352 | -35 | -2.5% | 6,800 |
2017/08/10 | 1,399 | 1,399 | 1,377 | 1,387 | -10 | -0.7% | 5,500 |
2017/08/09 | 1,408 | 1,408 | 1,381 | 1,397 | +19 | +1.4% | 14,100 |
2017/08/08 | 1,383 | 1,383 | 1,372 | 1,378 | +6 | +0.4% | 4,600 |
2017/08/07 | 1,379 | 1,379 | 1,368 | 1,372 | +6 | +0.4% | 6,500 |
2017/08/04 | 1,373 | 1,373 | 1,363 | 1,366 | ±0 | ±0% | 2,600 |
2017/08/03 | 1,352 | 1,367 | 1,352 | 1,366 | +14 | +1% | 5,200 |
2017/08/02 | 1,352 | 1,360 | 1,350 | 1,352 | ±0 | ±0% | 4,200 |
2017/08/01 | 1,355 | 1,355 | 1,351 | 1,352 | +1 | +0.1% | 3,100 |
2017/07/31 | 1,352 | 1,357 | 1,351 | 1,351 | -6 | -0.4% | 2,400 |
1701~
1750
件表示中 / 5390件
類似銘柄と比較する
現在ご覧いただいている「NJS」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NJS | 350,000円 | +2.2% | +73.1% | 2.71% | 15.86倍 | 1.25倍 |
|
上下水道のコンサルタント。官公需がほとんど。調査から設計・施工監理まで一貫。海外拠点多数 |
WDB | 175,900円 | +5.1% | -13.4% | 3.44% | 11.63倍 | 1.15倍 |
|
理学系研究職や研究補助職の人材派遣で首位。医薬品開発受託(CRO)や医薬関連事務も |
ITM | 167,300円 | +7.9% | +3.1% | 5.98% | 20.79倍 | 3.31倍 |
|
IT系ネットメディア運営。各種広告展開。営業見込み客情報提供するリードジェンを強化中 |
クリーク&リバ | 150,800円 | +10.4% | +16.0% | 2.85% | 10.29倍 | 2.05倍 |
|
テレビ・ゲーム・Web・広告等の派遣、制作が主。医療ほか専門職分野拡大。配当性向30%メド |
アイロムG | 278,500円 | - | - | - | - | 2.64倍 |
|
SMO(医療機関向け治験支援)主力。日・豪でCRO(医薬品開発受託)。MBO実施準備 |
市場注目の銘柄
チャート関連のコラム